Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006461 · ClinicalTrials.gov registry record · Phase 3
Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor
A Phase 3 study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 82
- Enrollment target
NCT00006461 is a Phase 3 study that has completed, run by Children's Oncology Group. The registered enrollment target is 82 participants.
The verdict
NCT00006461, a Phase 3 study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 82 participants
- Enrollment target
Study Summary
This phase III trial is studying how well combination chemotherapy followed by second-look surgery and radiation therapy works in treating children with nonmetastatic medulloblastoma or primitive neuroectodermal tumor. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one drug and combining chemotherapy with surgery and radiation therapy may kill more tumor cells.
Interventions
- DRUG cisplatin
- DRUG cyclophosphamide
- PROCEDURE therapeutic conventional surgery
- DRUG etoposide
- DRUG vincristine sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2000-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006461
The ClinicalTrials.gov registry entry for NCT00006461 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which cisplatin is the first listed.
NCT00006461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006461 about?
NCT00006461 is a clinical study titled "Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor". This phase III trial is studying how well combination chemotherapy followed by second-look surgery and radiation therapy works in treating children with nonmetastatic medulloblastoma or primitive neuroectodermal tumor. Drugs used in chemotherapy use different ways to stop tumor cells from dividing s...
What is the current status of trial NCT00006461?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 82 participants. The study started on 2000-10.
What interventions are being tested in trial NCT00006461?
The interventions under investigation include: cisplatin (DRUG), cyclophosphamide (DRUG), therapeutic conventional surgery (PROCEDURE), etoposide (DRUG), vincristine sulfate (DRUG).
Who is sponsoring clinical trial NCT00006461?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.